Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia

Neuropsychopharmacology

Volumn 18, Issue 1, 1998, Pages 1-9

  Bertolino, Alessandro ^a   Callicott, Joseph H ^a   Nawroz, Safia ^a   Mattay, Venkata S ^a   Duyn, Jozef H ^c   Tedeschi, Gioacchino ^b   Frank, Joseph A ^b   Weinberger, Daniel R ^a  

^a Clinical Brain Disorders Branch   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NONE

Author keywords

Frontal cortex; Hippocampus; N acetyl aspartate

Indexed keywords

CHOLINE; CLOZAPINE; CREATINE PHOSPHATE; HALOPERIDOL; N ACETYLASPARTIC ACID; RISPERIDONE;

ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REPRODUCIBILITY; SCHIZOPHRENIA; SIGNAL PROCESSING; STATISTICAL ANALYSIS;

ACETYLATION; ADULT; BRAIN CHEMISTRY; CHOLINE; CREATINE; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHOSPHOCREATINE; PREFRONTAL CORTEX; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA;

EID: 0031882658     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00090-0     Document Type: Article

References (38)

1. Alger JR, Frank JA, Bizzi A, Fulham M, DeSouza B, Duhaney MO, Inscoe SW, Black JL, van Zijl PCM, Moonen CTW, Di Chiro G Metabolism of human gliomas. Assessment with H-1 spectroscopy and F-18 fluorodeoxyglucose PET Radiology. 177:1990;633-641.
2. Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol. 36:1994;76-82.
3. Barker PB, Breiter SN, Soher BJ, Chatham JC, Forder JR, Samphilipo MA, Magee CA, Anderson JH Quantitative proton spectroscopy of canine brain. In vivo and in vitro correlations Magn Reson Med. 32(2):1994;157-163.
4. Barker PB, Gillard JH, van Zijl PCM, Soher BJ, Hanley DF, Agildere AM, Oppenheimer SM, Bryan RN Acute stroke. Evaluation with serial proton MR spectroscopic imaging Radiology. 192(3):1994;723-732.
5. Barker PB, Lee RR, McArthur JC AIDS dementia complex. Evaluation with proton MR spectroscopic imaging Radiology. 195:1995;58-64.
6. Bartko JJ, Carpenter WT Jr. On the methods and theory of reliability. J Nerv Ment Dis. 163:1976;307-317.
7. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CTW, Frank JA, Tedeschi G, Weinberger DR A specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry; 153:1996;1554-1563.
8. Bizzi A, Movsas B, Tedeschi G, Phillips CL, Okunieff P, Alger JR, Di Chiro G Response of non-Hodgkin lymphoma to radiation therapy. Early and long-term assessment with H-1 MR spectroscopic imaging Radiology. 194:1995;271-276.
9. Buckley PF, Moore C, Long H, Larkin C, Thompson P, Mulvany F, Redmond O, Stack JP, Ennis JT, Waddington JL 1H Magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia. Clinical, neurodevelopmental and cognitive correlates Biol Psychiatry. 36:1994;792-800.
10. Cazzaniga S, Schold SC Jr., Sostman HD, Charles HC Effects of therapy on the 1H NMR spectrum of a human glioma line. Magn Reson Imaging. 12(6):1994;945-950.
11. Charles HC, Lazeyras F, Tupler LA, Krishnan KRR Reproducibility of high spatial resolution proton magnetic resonance spectroscopic imaging in the human brain. MRM. 35:1996;606-610.
12. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology. 44:1994;1411-1417.
13. Davie CA, Hawkins CP, Barker GJ, Brennan J, Tofts PF, Miller DH, McDonald WI Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 117:1994;49-58.
14. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CTW Multisection proton MR spectroscopic imaging of the brain. Radiology. 188:1993;277-282.
15. Frahm J, Bruhn H, Gyngell ML, Merboldt, Hanicke W, Sauter R (1989): Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 11:47-63.
16. Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, Obo Y, Ueyama K, Takigawa M, Fujimoto T Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia. Preliminary report Psychiatry Res Neuroimaging. 61:1995;193-200.
17. Hennig J, Pfister H, Ernst T, Ott D Direct absolute quantification of metabolites in the human brain with in vivo localized spectroscopy. NMR Biomed. 5:1992;193-199.
18. Hetherington H, Kuzniecky R, Pan J, Mason G, Morawetz R, Harris C, Faught E, Vaughan T, Pohost G Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol. 38:1995;396-404.
19. Jackson EF, Doyle TJ, Wolinsky JS, Narayana PA Short TE hydrogen-1 spectroscopic imaging of normal human brain. Reproducibility studies JMRI. 4:1994;545. 551.
20. Jenkins BG, Koroshetz WJ, Beal FM, Rosen BR Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology. 43:1993;2689-2695.
21. Kruse B, Barker PB, van Zijl PCM, Duyn JH, Moonen CTW, Mosr HW Multislice proton magnetic resonance spectroscopic imaging in x-linked adrenoleukodystrophy. Ann Neurol. 36:1994;595-608.
22. Maier M, Ron MA, Barker GJ, Tofts PS Proton magnetic resonance spectroscopy. An in vivo method of estimating hippocampal neuronal depletion in schizophrenia Psychol Med. 25:1995;1201-1209.
23. Meyerhoff DJ, MacKay S, Constans J-M, Norman D, Van Dyke C, Fein G, Weiner MW Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol. 36:1994;40-47.
24. Miller BL A review of chemical issues in 1H NMR spectroscopy. N-acetyl-L-aspartate, creatine and choline NMR Biomed. 4:1991;47-52.
25. Murata T, Koshino Y, Omori M, Murata I, Nishio M, Horie T, Umezawa Y, Isaki K, Kimura H, Itoh S, Maeda M, Ishii Y In vivo proton magnetic resonance spectroscopy study on premature aging in adult Down's syndrome. Biol Psychiatry. 34:1993;290-297.
26. Nakakoshi T, Matsuzawa H, Houkin K, Miyasaka K, Arimoto T Two cases of proton MR spectroscopy of the brain after irradiation. Radiat Med. 12:1994;139-142.
27. Narayana PA, Johnston D, Flamig D In vivo proton magnetic resonance spectroscopy studies of human brain. Magn Reson Imaging. 9:1991;303-308.
28. Nasrallah HA, Skinner TE, Schmalbrock P, Robitaille PM Proton magnetic resonance spectroscopy of the hippocampal formation in schizophrenia. A pilot study Br J Psychiatry. 165:1994;481-485.
29. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen B Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry. 152:1995;444-446.
30. Roser W, Hagberg G, Mader I, Brunnschweiler H, Radue EW, Seelig J, Kappos L Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med. 33(6):1995;811-817.
31. Tedeschi G, Schiffmann R, Barton NW, Shih HH-L, Gospe SM, Brady RO, Alger JR, Di Chiro G Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination. Neurology. 45:1995;1526-1532.
32. Tedeschi G, Bertolino A, Righini A, Campbell G, Raman R, Duyn JH, Moonen CTW, Alger JR, Di Chiro G Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology. 45:1995;1384-1391.
33. Tedeschi G, Bertolino A, Massaquoi SG, Campbell G, Patronas NJ, Bonavita S, Barnett AS, Alger JR, Hallett M Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration. Ann Neurol. 39:1996;71-78.
34. Urenjak J, Williams SR, Gadian DG, Noble M Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 13:1993;981-989.
35. Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone P Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet. 345:1995;60-61.
36. Weinberger DR Schizophrenia. From neuropathology to neurodevelopment Lancet. 346:1995;552-557.
37. Weinberger DR, Lipska BK Cortical maldevelopment, anti-psychotic drugs and schizophrenia. A search for common ground Schizophr Res. 16:1995;87-110.
38. Yurgelun-Todd DA, Renshaw PF, Gruber SA, Waternaux CM, Cohen BM Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr Res. 19:1996;55-59.